Daito Pharmaceutical Co., Ltd.(JP:4577)
¥1,310.00+2.00 (+0.15%)
JP:4577
Daito Pharmaceutical Co., Ltd. Revenue
¥1,310.00
At close:+2.00 (+0.15%)
Want to see JP:4577 full AI Analyst Report?
Daito Pharmaceutical Co., Ltd. (4577) Revenue
0 Followers
Daito Pharmaceutical Co., Ltd. Revenue
Daito Pharmaceutical Co., Ltd. had a revenue of 11.89B in the quarter ending Aug 31, 2025, with -14.54%. This bring the company's revenue in the last twelve months to 49.53B, Decreased 2.21%. In the fiscal year ending May 31, 2025, Daito Pharmaceutical Co., Ltd. had annual revenue of 50.65B with 0.01% growth.
- Revenue (ttm)
- 49.53B
- Revenue Growth
- -2.83%
- P/S Ratio
- 0.75
- Revenue/Employee
- JPY 46,682,028
- Employees
- 1,085
- Market Cap
- JPY 37.73B
Revenue Chart
Daito Pharmaceutical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 50.65B | 7.00M | 0.01% |
| May 31, 2024 | 50.64B | 3.75B | 7.99% |
| May 31, 2023 | 46.90B | 1.79B | 3.98% |
| May 31, 2022 | 45.10B | 1.64B | 3.77% |
| May 31, 2021 | 43.46B | -5.25B | -10.77% |
| May 31, 2020 | 48.71B | 3.71B | 8.25% |
| May 31, 2020 | 45.00B | 3.86B | 9.39% |
| May 31, 2019 | 41.14B | 1.25B | 3.14% |
| May 31, 2018 | 39.88B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.